NASDAQ:HRTX

Heron Therapeutics SEC Filings & 10K Form

$15.77
+0.37 (+2.40 %)
(As of 06/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.37
$15.78
50-Day Range
$13.27
$18.48
52-Week Range
$12.52
$22.40
Volume1.08 million shs
Average Volume1.35 million shs
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.39

Heron Therapeutics (NASDAQ:HRTX) SEC Filings

DateFilerForm TypeView
05/28/2021
3:19 PM
Heron Therapeutics (Filer)
Form S-3ASR
05/25/2021
8:04 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2021
7:25 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
7:45 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2021
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2021
5:03 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2021
3:15 PM
Heron Therapeutics (Filer)
Form DEFA14A
04/16/2021
7:59 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2021
4:04 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
7:46 AM
Heron Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
3:15 PM
Heron Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G/A
02/16/2021
12:29 PM
ArrowMark Colorado Holdings LLC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
02/11/2021
12:43 PM
Heron Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/04/2021
10:27 AM
Heron Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/01/2021
1:39 PM
FRANKLIN RESOURCES INC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
01/21/2021
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
5:07 PM
Heron Therapeutics (Issuer)
Szekeres David Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:24 PM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:23 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:21 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:21 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:20 PM
DAVIS STEPHEN (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
3:00 PM
Heron Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
11/13/2020
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:45 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2020
4:16 PM
Heron Therapeutics (Issuer)
Szekeres David Leslie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
3:35 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:28 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
3:25 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:24 PM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:23 PM
Heron Therapeutics (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:21 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:20 PM
DAVIS STEPHEN (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
7:30 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
7:30 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
7:41 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2020
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
7:41 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2020
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2020
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
10:38 AM
FMR LLC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
06/29/2020
3:06 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2020
8:14 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
8:11 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
8:16 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2020
8:10 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2020
5:48 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
3:05 PM
Heron Therapeutics (Filer)
Form DEF 14A
04/17/2020
8:08 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
8:07 PM
DAVIS STEPHEN (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
6:47 AM
Heron Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/02/2020
6:44 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:56 PM
Heron Therapeutics (Issuer)
Quart Barry D (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
3:14 PM
BAKER BROS. ADVISORS LP (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
02/13/2020
2:48 PM
Heron Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/05/2020
10:45 AM
BlackRock Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
01/13/2020
7:41 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
2:11 PM
Heron Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/07/2020
12:44 PM
Heron Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
12/23/2019
3:29 PM
Heron Therapeutics (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:29 PM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
3:06 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:15 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
5:30 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
6:41 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
7:46 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
7:41 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
7:42 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:01 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
4:18 PM
Heron Therapeutics (Issuer)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2019
3:28 PM
Heron Therapeutics (Filer)
Form 424B2
10/04/2019
6:58 PM
Heron Therapeutics (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
6:56 PM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:03 PM
Heron Therapeutics (Filer)
Form 424B5
10/02/2019
6:57 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
7:09 PM
DAVIS STEPHEN (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
7:06 PM
DAVIS STEPHEN (Reporting)
Heron Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2019
3:25 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
3:16 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
7:42 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
7:35 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
3:53 PM
Heron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/05/2019
7:46 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
7:40 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
7:48 AM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
7:30 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:05 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
7:39 AM
Heron Therapeutics (Issuer)
POYHONEN JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
8:15 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
7:44 AM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
7:35 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
7:40 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
7:35 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
7:40 PM
Heron Therapeutics (Issuer)
MANHARD KIMBERLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
7:06 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:44 PM
Heron Therapeutics (Filer)
Form DEF 14A
This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.